Neutropenia in patients treated with thienopyridines and high-dose oral prednisone after percutaneous coronary interventions

Journal of Interventional Cardiology

Volumn 20, Issue 3, 2007, Pages 209-213

  Ribichini, Flavio ^a   Ferrero, Valeria ^a   Feola, Mauro ^b   Rognoni, Andrea ^c   Brunelleschi, Sandra ^c   Vacca, Giovanni ^c   Vassanelli, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTACID AGENT; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISONE; TICLOPIDINE;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BLOOD CELL COUNT; DRUG MEGADOSE; DRUG WITHDRAWAL; EDEMA; HUMAN; HYPERTENSION; INFECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; SIDE EFFECT; SODIUM RETENTION; STOMACH PAIN; UNSTABLE ANGINA PECTORIS; WATER RETENTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFECTIVE AGENTS; CORONARY RESTENOSIS; DRUG TOXICITY; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PREDNISONE; PROSPECTIVE STUDIES; PYRIDINES; RISK FACTORS;

EID: 34249286247     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00256.x     Document Type: Article

References (21)

1. Ribichini F, Joner M, Ferrero V, et al. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol 2007 in press.
2. Versaci F, Gaspardone A, Tomai F, et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 2002 40 : 1935 1942.
3. Ribichini F, Tomai F, Ferrero V, et al. Immunosuppressive oral prednisone after percutaneous interventions in patients with multivessel coronary artery disease. The IMPRESS-2/MVD study. Eurointervention 2005 2 : 173 180.
4. Ribichini F, Ferrero V, Rognoni A, et al. Percutaneous treatment of coronary bifurcations: Lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y Study. J Interven Cardiol 2007 in press.
5. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in native coronary arteries. N Engl J Med 2003 349 : 1315 1323.
6. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 350 : 221 231.
7. Morice MC, Colombo A, Meier B, et al. Sirolimus vs paclitaxel-eluting stents in de novo coronary artery lesions. The reality trial: A randomized controlled trial. JAMA 2006 295 : 895 904.
8. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids. New mechanisms for old drugs. N Engl J Med 2005 353 : 1711 1723.
9. Ferrero V, Ribichini F, Rognoni A, et al. Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary intervention. The IMPRESS-LD Study. Am J Cardiol 2007 in press.
10. Palmblad J, Papadaki HA, Eliopoulos G. Acute and chronic neutropenia. What is new J Inter Med 2002 250 : 476 491.
11. Schaub S, Dickenmann M, Cynke E, et al. Prednisone-induced neutropenia after cadaveric kidney transplantation. Nephrol Dial Transplant 2002 17 : 1119 1121.
12. Bhatt V, Saleem A. Review: Drug-induced neutropenia. Pathophysiology, clinical features, and management. Ann Clin Lab Sci 2004 34 : 131 137.
13. Symeonidis A, Kouraklis-Symeonidis A, Seimeni U, et al. Ticlopidine-induced aplastic anemia: Two new case reports, review and meta-analysis of 55 additional cases. Am J Hematol 2002 71 : 1191 1221.
14. Jarvis B, Simpson K. Clopidogrel: A review of its use in the prevention of atherothrombosis. Drugs 2000 60 : 347 377.
15. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). The Lancet 1996 348 : 1329 1338.
16. Quinn MJ, Fitzgerald DJ. Ticlopidine and Clopidogrel. Circulation 1999 100 : 1667 1672.
17. Redlich K, Parschalk B, Ehringer H, et al. Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C. Vasa 1999 28 : 301 303.
18. Pereillo JM, Maftouh M, Andrieu A, et al. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab Dispos 2002 30 : 1288 1295.
19. Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: A tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003 1619 : 243 253.
20. Almsherqi ZA, McLachlan CS, Sharef SM. Non-bleeding side effects of clopidogrel: Have large multi-center clinical trials underestimated their incidence Int J Cardiol 2006 Aug 17; [Epub ahead of print].
21. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 293 : 2126 2130.